Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

Completed · Phase 4

Conditions studied: Pterygia

In brief

To Determine if topical cyclosporine 0.05% BID prevents recurrent inflammation and improves comfort in eyes with pterygia.

Key facts

Study ID

NCT00383396

Run by

Innovative Medical

Last updated by the study team

2007-02-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• pts with symptomatic pterygia unresponsive to palliative treatment.

Where it is running

• Dr. Schechter — Boynton Beach, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.